173 related articles for article (PubMed ID: 33839156)
21. Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19.
Agrawal V; Huang N; Miller WL
Pharmacogenet Genomics; 2008 Jul; 18(7):569-76. PubMed ID: 18551037
[TBL] [Abstract][Full Text] [Related]
22. Application of methyl-TROSY to a large paramagnetic membrane protein without perdeuteration:
Galiakhmetov AR; Kovrigina EA; Xia C; Kim JP; Kovrigin EL
J Biomol NMR; 2018 Jan; 70(1):21-31. PubMed ID: 29168021
[TBL] [Abstract][Full Text] [Related]
23. Uncovering the role of hydrophobic residues in cytochrome P450-cytochrome P450 reductase interactions.
Kenaan C; Zhang H; Shea EV; Hollenberg PF
Biochemistry; 2011 May; 50(19):3957-67. PubMed ID: 21462923
[TBL] [Abstract][Full Text] [Related]
24. The binding affinity of carcinogenic N-nitrosodimethylamine and N-nitrosomethylaniline to cytochromes P450 2B4, 2E1 and 3A6 does not dictate the rate of their enzymatic N-demethylation.
Sulc M; Hodek P; Stiborová M
Gen Physiol Biophys; 2010 Jun; 29(2):175-85. PubMed ID: 20577029
[TBL] [Abstract][Full Text] [Related]
25. Examining the mechanism of stimulation of cytochrome P450 by cytochrome b5: the effect of cytochrome b5 on the interaction between cytochrome P450 2B4 and P450 reductase.
Reed JR; Hollenberg PF
J Inorg Biochem; 2003 Nov; 97(3):265-75. PubMed ID: 14511889
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome b5 inhibits electron transfer from NADPH-cytochrome P450 reductase to ferric cytochrome P450 2B4.
Zhang H; Hamdane D; Im SC; Waskell L
J Biol Chem; 2008 Feb; 283(9):5217-25. PubMed ID: 18086668
[TBL] [Abstract][Full Text] [Related]
27. Functional interactions between cytochromes P450 1A2 and 2B4 require both enzymes to reside in the same phospholipid vesicle: evidence for physical complex formation.
Reed JR; Eyer M; Backes WL
J Biol Chem; 2010 Mar; 285(12):8942-52. PubMed ID: 20071338
[TBL] [Abstract][Full Text] [Related]
28. Influence of various polymorphic variants of cytochrome P450 oxidoreductase (POR) on drug metabolic activity of CYP3A4 and CYP2B6.
Chen X; Pan LQ; Naranmandura H; Zeng S; Chen SQ
PLoS One; 2012; 7(6):e38495. PubMed ID: 22719896
[TBL] [Abstract][Full Text] [Related]
29. Cytochrome b5 increases the rate of product formation by cytochrome P450 2B4 and competes with cytochrome P450 reductase for a binding site on cytochrome P450 2B4.
Zhang H; Im SC; Waskell L
J Biol Chem; 2007 Oct; 282(41):29766-76. PubMed ID: 17693640
[TBL] [Abstract][Full Text] [Related]
30. Cytochrome P450 system proteins reside in different regions of the endoplasmic reticulum.
Park JW; Reed JR; Brignac-Huber LM; Backes WL
Biochem J; 2014 Dec; 464(2):241-9. PubMed ID: 25236845
[TBL] [Abstract][Full Text] [Related]
31. Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.
Flück CE; Nicolo C; Pandey AV
Fundam Clin Pharmacol; 2007 Aug; 21(4):399-410. PubMed ID: 17635179
[TBL] [Abstract][Full Text] [Related]
32. Photo-initiated crosslinking extends mapping of the protein-protein interface to membrane-embedded portions of cytochromes P450 2B4 and b₅.
Ječmen T; Ptáčková R; Černá V; Dračínská H; Hodek P; Stiborová M; Hudeček J; Šulc M
Methods; 2015 Nov; 89():128-37. PubMed ID: 26235815
[TBL] [Abstract][Full Text] [Related]
33. Ferrous and ferric state of cytochromes P450 in intact Escherichia coli cells: a possible role of cytochrome P450-flavodoxin interactions.
Culka M; Milichovsky J; Jerabek P; Stiborova M; Martinek V
Neuro Endocrinol Lett; 2015; 36 Suppl 1():29-37. PubMed ID: 26757119
[TBL] [Abstract][Full Text] [Related]
34. Influence of ionic strength on the P450 monooxygenase reaction and role of cytochrome b5 in the process.
Schenkman JB; Voznesensky AI; Jansson I
Arch Biochem Biophys; 1994 Oct; 314(1):234-41. PubMed ID: 7944401
[TBL] [Abstract][Full Text] [Related]
35. Evidence supporting the interaction of CYP2B4 and CYP1A2 in microsomal preparations.
Cawley GF; Zhang S; Kelley RW; Backes WL
Drug Metab Dispos; 2001 Dec; 29(12):1529-34. PubMed ID: 11717170
[TBL] [Abstract][Full Text] [Related]
36. Resonance Raman studies of cytochrome P450 2B4 in its interactions with substrates and redox partners.
Mak PJ; Im SC; Zhang H; Waskell LA; Kincaid JR
Biochemistry; 2008 Mar; 47(12):3950-63. PubMed ID: 18311926
[TBL] [Abstract][Full Text] [Related]
37. Environmentally persistent free radical-containing particulate matter competitively inhibits metabolism by cytochrome P450 1A2.
Reed JR; dela Cruz AL; Lomnicki SM; Backes WL
Toxicol Appl Pharmacol; 2015 Dec; 289(2):223-30. PubMed ID: 26423927
[TBL] [Abstract][Full Text] [Related]
38. Single molecule activity measurements of cytochrome P450 oxidoreductase reveal the existence of two discrete functional states.
Laursen T; Singha A; Rantzau N; Tutkus M; Borch J; Hedegård P; Stamou D; Møller BL; Hatzakis NS
ACS Chem Biol; 2014 Mar; 9(3):630-4. PubMed ID: 24359083
[TBL] [Abstract][Full Text] [Related]
39. Influence of mutation of the amino-terminal signal anchor sequence of cytochrome P450 2B4 on the enzyme structure and electron transfer processes.
Lehnerer M; Schulze J; Pernecky SJ; Lewis DF; Eulitz M; Hlavica P
J Biochem; 1998 Aug; 124(2):396-403. PubMed ID: 9685732
[TBL] [Abstract][Full Text] [Related]
40. Identification of key residues in rabbit liver microsomal cytochrome P450 2B4: importance in interactions with NADPH-cytochrome P450 reductase.
Lehnerer M; Schulze J; Achterhold K; Lewis DF; Hlavica P
J Biochem; 2000 Jan; 127(1):163-9. PubMed ID: 10731679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
